TickerFactsScreenerDevelopers

Cartesian Therapeutics, Inc. (RNAC) — Revenue

Annual figures by fiscal year, from SEC filings.

2017: $207.0K2018: $903.0K2019: $6.68M2020: $16.60M2021: $85.08M2022: $110.78M2023: $26.00M2024: $38.27M2025: $400.0K$400.0K
2017Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$400.0K-99.0%
2024$38.27M+47.2%
2023$26.00M-76.5%
2022$110.78M+30.2%
2021$85.08M+412.6%
2020$16.60M+148.6%
2019$6.68M+639.4%
2018$903.0K+336.2%
2017$207.0K—